CA A Cancer Journal for Clinicians· 2017Q1
Colorectal cancer statistics, 2017
- 3,876citations
- Q1SCImago
- 2017year
Short summary
Colorectal cancer (CRC) incidence and mortality rates have decreased by 32% and 34% respectively in adults aged ≥50 years between 2000-2013 and 2000-2014, but have increased by 22% and 13% in adults aged <50 years during the same period.
AI-generated from the title and abstract; the full text is not read.
Key points
- CRC incidence in adults ≥50 years declined 32% (2000-2013), with the largest drop in distal tumors for those ≥65 years (IRR 0.50).
- CRC incidence in adults <50 years increased 22% (2000-2013), driven by distal colon and rectal tumors (IRR 1.24 and 1.22 respectively).
- CRC death rates decreased 34% in adults ≥50 years (2000-2014) but increased 13% in adults <50 years.
- Incidence rates vary by race/ethnicity and sex, with higher rates in Alaska Natives and blacks, and 30%-40% higher in men than women.
AI-generated from the title and abstract; the full text is not read.
Abstract
Colorectal cancer (CRC) is one of the most common malignancies in the United States. Every 3 years, the American Cancer Society provides an update of CRC incidence, survival, and mortality rates and trends. Incidence data through 2013 were provided by the Surveillance, Epidemiology, and End Results program, the National Program of Cancer Registries, and the North American Association of Central Cancer Registries. Mortality data through 2014 were provided by the National Center for Health Statistics. CRC incidence rates are highest in Alaska Natives and blacks and lowest in Asian/Pacific Islanders, and they are 30% to 40% higher in men than in women. Recent temporal patterns are generally similar by race and sex, but differ by age. Between 2000 and 2013, incidence rates in adults aged ≥50 years declined by 32%, with the drop largest for distal tumors in people aged ≥65 years (incidence rate ratio [IRR], 0.50; 95% confidence interval [95% CI], 0.48-0.52) and smallest for rectal tumors in ages 50 to 64 years (male IRR, 0.91; 95% CI, 0.85-0.96; female IRR, 1.00; 95% CI, 0.93-1.08). Overall CRC incidence in individuals ages ≥50 years declined from 2009 to 2013 in every state except Arkansas, with the decrease exceeding 5% annually in 7 states; however, rectal tumor incidence in those ages 50 to 64 years was stable in most states. Among adults aged <50 years, CRC incidence rates increased by 22% from 2000 to 2013, driven solely by tumors in the distal colon (IRR, 1.24; 95% CI, 1.13-1.35) and rectum (IRR, 1.22; 95% CI, 1.13-1.31). Similar to incidence patterns, CRC death rates decreased by 34% among individuals aged ≥50 years during 2000 through 2014, but increased by 13% in those aged <50 years. Progress against CRC can be accelerated by increasing initiation of screening at age 50 years (average risk) or earlier (eg, family history of CRC/advanced adenomas) and eliminating disparities in high-quality treatment. In addition, research is needed to elucidate causes for increasing CRC in young adults. CA Cancer J Clin 2017. © 2017 American Cancer Society. CA Cancer J Clin 2017;67:177-193. © 2017 American Cancer Society.
The authors' abstract, as published at the source. CA A Cancer Journal for Clinicians, 2017 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Oncology
OncologyMedicine